A detailed history of Park Place Capital Corp transactions in Organon & Co. stock. As of the latest transaction made, Park Place Capital Corp holds 170 shares of OGN stock, worth $2,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170
Previous 70 142.86%
Holding current value
$2,560
Previous $1,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$18.65 - $23.03 $1,864 - $2,303
100 Added 142.86%
170 $3,000
Q4 2023

Jan 24, 2024

SELL
$10.95 - $17.32 $98 - $155
-9 Reduced 11.39%
70 $1,000
Q3 2023

Oct 17, 2023

BUY
$16.59 - $23.77 $149 - $213
9 Added 12.86%
79 $1,000
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $1,631 - $2,002
70 New
70 $2,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.83B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.